The Lancet Neurology in conversation with
By The Lancet Group
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by The Lancet Group
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 33
Reviews: 0
Episodes: 73
Description
Explore the latest breakthroughs in brain health and neurological disease through interviews with leading researchers, neurologists, and policy experts. Each episode breaks down complex topics for a broad audience, translating cutting-edge science into practical insights.
Editors at The Lancet Neurology, the world-leading clinical neurology journal, interview the investigators at the forefront of stroke, Alzheimer’s disease, epilepsy, migraine, Parkinson’s disease, multiple sclerosis, sleep disorders, traumatic brain injury, and other neurological challenges.
| Episode | Date |
|---|---|
|
The future of Alzheimer’s disease: blood biomarkers, brain imaging, and screening the cognitively unimpaired
|
Sep 09, 2026 |
|
Marjo van der Knaap on vanishing white matter
|
Aug 12, 2026 |
|
Jan D Lünemann and Christian Münz on Epstein–Barr virus and multiple sclerosis
|
Jul 15, 2026 |
|
Hal Dietz discusses the role of genetics in spinal CSF leaks
|
Jun 17, 2026 |
|
Tony Schapira on GBA1 Parkinson's disease
|
Jun 16, 2026 |
|
Henry Brodaty and Alice Powell on cognitive resilience and ageing
|
Apr 17, 2026 |
|
Niklas Mattsson-Carlgren on the use of biomarkers in the diagnosis and stratification of Alzheimer’s disease
|
Mar 18, 2026 |
|
Cristina Tassorelli on migraine prevention
|
Feb 18, 2026 |
|
Inga Zerr and Simon Mead on advances in prion diseases
|
Jan 21, 2026 |
|
Julia Greenland on azathioprine for early Parkinson’s disease
|
Dec 19, 2025 |
|
Ian McKeith on dementia with dementia with Lewy bodies
|
Nov 12, 2025 |
|
Ask Nordestgaard on long-term stroke risk in women
|
Oct 15, 2025 |
|
Shiv Saidha on recent updates in the diagnosis of multiple sclerosis
|
Sep 17, 2025 |
|
Michael Rafii on Down syndrome-related Alzheimer’s disease
|
Aug 13, 2025 |
|
Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis
|
Jul 16, 2025 |
|
Marte-Helene Bjørk on reproductive risks in people with epilepsy
|
Jun 17, 2025 |
|
Geoff Manley on a new classification system for traumatic brain injury
|
May 20, 2025 |
|
Wayne Feng on stroke rehabilitation using brain stimulation and constraint-induced movement therapy
|
Apr 16, 2025 |
|
Marialuisa Gandolfi on the management of chronic pain in Parkinson’s disease
|
Mar 19, 2025 |
|
Michael Tymianski on neuroprotection in stroke
|
Feb 19, 2025 |
|
Elizabeth Finger on oxytocin for apathy in frontotemporal dementia
|
Jan 22, 2025 |
|
The Lancet Neurology Editors on advances in neurology in 2024
|
Dec 18, 2024 |
|
Florian Krismer and Elizabeth Coon on multiple system atrophy
|
Nov 20, 2024 |
|
Suvankar Pal on the motor neuron disease trial MND-SMART
|
Oct 16, 2024 |
|
Jorge Correale and Lilyana Amezcua on differential diagnosis of multiple sclerosis
|
Sep 18, 2024 |
|
Alex Iranzo on sleep and Parkinson’s disease
|
Aug 14, 2024 |
|
Adrian Owen on detecting awareness after acute brain injury
|
Jul 17, 2024 |
|
Glenn Nielsen on specialist physiotherapy for people with functional motor disorder
|
Jun 12, 2024 |
|
Sanjay Sisodiya on climate change and brain health
|
May 15, 2024 |
|
Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy
|
Apr 15, 2024 |
|
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system
|
Mar 14, 2024 |
|
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders
|
Feb 14, 2024 |
|
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy
|
Jan 22, 2024 |
|
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury
|
Dec 13, 2023 |
|
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage
|
Nov 15, 2023 |
|
Njideka Okubadejo and Mie Rizig on Parkinson’s disease in African and African admixed populations
|
Oct 20, 2023 |
|
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
|
Sep 20, 2023 |
|
William Jagust on amyloid β and cognition
|
Aug 16, 2023 |
|
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury
|
Jul 19, 2023 |
|
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases
|
Jun 21, 2023 |
|
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma
|
May 18, 2023 |
|
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation
|
Apr 13, 2023 |
|
Kerstin Hellwig on family planning considerations in MS
|
Mar 15, 2023 |
|
Geraldine Dawson on advances in the prediction of autism during infancy
|
Feb 16, 2023 |
|
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke
|
Jan 19, 2023 |
|
Beau Ances on amyloid biomarkers in Alzheimer’s
|
Dec 12, 2022 |
|
Axel Petzold on the diagnosis and classification of optic neuritis
|
Nov 16, 2022 |
|
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery
|
Oct 18, 2022 |
|
Jerome Siegel on sleep habits
|
Sep 14, 2022 |
|
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy
|
Aug 10, 2022 |
|
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
|
Jul 13, 2022 |
|
Sarah Tabrizi and Cristina Sampaio on classifying Huntington’s and new therapies
|
Jun 15, 2022 |
|
Mark Hallett on functional neurological disorder
|
May 13, 2022 |
|
Eva Feldman on advances in understanding ALS
|
Apr 13, 2022 |
|
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer’s
|
Apr 06, 2022 |
|
John Collinge on a treatment for CJD
|
Mar 16, 2022 |
|
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2
|
Feb 22, 2022 |
|
Giuseppe Citerio on frailty and TBI
|
Jan 19, 2022 |
|
Alberto Costa on memantine in adolescents and young adults with Down syndrome
|
Dec 20, 2021 |
|
Olivier Rascol on amantadine for patients with movement disorders
|
Nov 17, 2021 |
|
Antonio Uccelli on stems cells for MS
|
Oct 20, 2021 |
|
Priya Palta on blood pressure control and cognitive decline
|
Sep 15, 2021 |
|
Adam Boxer on tau biomarkers
|
Aug 18, 2021 |
|
Irene Cortese on the difficulties of designing clinical trials
|
Jul 21, 2021 |
|
Doug Turnbull on mitochondrial diseases in adults
|
Jun 16, 2021 |
|
Geert Jan Biessels on predicting post-stroke cognitive impairment
|
May 19, 2021 |
|
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
|
Apr 21, 2021 |
|
Anne MacGregor on menstrual migraine
|
Mar 17, 2021 |
|
Peter Rothwell on asymptomatic carotid stenosis and stroke
|
Feb 17, 2021 |
|
Spinal cord injury and degenerative cervical myelopathy
|
Jan 20, 2021 |
|
Genetic risk factors for sCJD
|
Dec 22, 2020 |
|
Prednisone in short-term prevention of cluster headache
|
Nov 24, 2020 |
|
PET imaging of inflammation in neurological and psychiatric disorders
|
Oct 21, 2020 |